Home Trending Stocks What’s driving investors toward Bionano Genomics (BNGO), Is it worth a Buy?

What’s driving investors toward Bionano Genomics (BNGO), Is it worth a Buy?

There’s a recent push in Bionano stock after the Nasdaq compliance update and that’s what BNGO wants.

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

Bionano Genomics (BNGO) has been astonishing during this whole month. In December 2020, shares of the biosciences soared over 328%, which is quite magnificent.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


In the past couple of days, Bionano has attracted a significant number of investors, thanks to the update from Nasdaq for granting more time to regain compliance. At the moment, the momentum is on BioNano’s side, but will it continue in the upcoming times? Let’s have a look.

What’s happening around?

Bionano Genomics is a biosciences firm that provides unparalleled structural variation detection for cancer research, genetic disease research, and cytogenomics with genome imaging.

On Dec. 28, 2020, the company revealed that its genome mapping platform Saphyr has obtained authorization from the College of American Pathologists in the U.S. The platform is being developed for Bionano’s customer Praxis Genomics.

If things go Bionano’s way, it will become the first company to provide a laboratory-developed test (LDT), along with entire support of genome analysis. Saphyr’s optical genome mapping will replace the conventional cytogenetic methods and this could bring a massive change in LDT.

According to Maxim’s analyst Jason McCarthy, Saphyr can be a game-changer for Bionano. Saphyr can make a major difference in digital cytogenetics and can potentially revolutionize the clinical diagnostic ecosystem.

If Saphyr becomes successful in replacing the traditional methods, it would help in reducing time and hefty costs. At the end of the day, this would bring more revenue for Bionano, which would be a big accomplishment.

In the U.S., it’s for the first time that any product like Saphyr was accredited. In Europe, there are entire genome clinical tests, which are already under development in different applications including leukemia and inherited genetic disorders.

Things are shaping up pretty nicely for Bionano Genomics. First, accreditation of Saphyr in the U.S. and now, Nasdaq has granted more days to regain compliance with Nasdaq’s minimum $1 per share closing bid price requirement.

This update from Nasdaq means that the company has time until June 28, 2021, to regain compliance on the stock market. Previously, the company has time until December 16, 2020, to meet the minimum $1 per share requirement.

This news brought a new wave of investors and the stock soared over the $2 price mark. That’s what Bionano wants to maintain for almost 10 consecutive days. If the stock remains at or above $1 per share, Nasdaq will list the stock back to the market for trading.

There’s a fair bit of tilt from investors as the average trading volume of BNGO stock is around 24.4 million.

Conclusion

Things seem good for BioNano Genomics (BNGO) and analysts are also bullish on the stock. If the company goes on to regain compliance, then things will open up for the biosciences firm.

Get the hottest stocks to trade every day before the ‎market opens 100% ‎free. Click here now. 

Moreover, a major deal lies in Saphyr if we analyze long-term opportunities for the company. If Saphyr goes through a successful trial and attains regulatory authorization, it would be massive feat for BioNano.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

3 Best Work-From-Home Stocks for Long-term Investment

The work-from-home stocks have made a great room following the pandemic impact. The term “work-from-home” has become quite familiar after the COVID-19 pandemic hike...

Top 3 Fintech Stocks to Buy in 2021

Fintech firms are in high demand as the world looks for new financial services alternatives.  Fintech has evolved over the years—the finance-tech combo has...

Top 3 Cloud Computing Stocks to Watch For in 2021

The cloud computing industry ranks among the top markets—a marketplace that is worth investing in. Cloud computing is the most advanced technology in the...

The Top Cryptocurrency Stocks Flight in the Market for long-term

Do you know about Bitcoin and cryptocurrencies? If so, here are the top 3 cryptocurrency stocks for long-term investment. The future of cryptocurrency seems more...

Is Zomedica Corp. (ZOM) a Buy with the Recent Dip?

‎Zomedica is ready to initiate a new diagnostic platform that has backed its share price in recent times. But, what’s with this recent drop...

So, this update pushing Zomedica Corp. (NYSE American: ZOM) stock up in the morning session

Zomedica Corp. (NYSE American: ZOM) stock was up trending higher than 12.8%  to $1.1000 in the early morning trading session as it released the...

What Is Causing Neovasc’s (NVCN) Shares To Fall Today?

Shares of Neovasc Inc (NVCN), a developer, manufacturer, and seller of specialty medical devices and products for the rapidly growing cardio market, have been...

What to Expect When The Procter & Gamble Company [PG] Announces Earnings

The Procter & Gamble Company will report earnings after markets close on Wednesday, January 20th. Get the hottest stocks to trade every day...

Related News

3 Best Work-From-Home Stocks for Long-term Investment

The work-from-home stocks have made a great room following the pandemic impact. The term “work-from-home” has become quite familiar after the COVID-19 pandemic hike...

Top 3 Fintech Stocks to Buy in 2021

Fintech firms are in high demand as the world looks for new financial services alternatives.  Fintech has evolved over the years—the finance-tech combo has...

Top 3 Cloud Computing Stocks to Watch For in 2021

The cloud computing industry ranks among the top markets—a marketplace that is worth investing in. Cloud computing is the most advanced technology in the...

The Top Cryptocurrency Stocks Flight in the Market for long-term

Do you know about Bitcoin and cryptocurrencies? If so, here are the top 3 cryptocurrency stocks for long-term investment. The future of cryptocurrency seems more...

Is Zomedica Corp. (ZOM) a Buy with the Recent Dip?

‎Zomedica is ready to initiate a new diagnostic platform that has backed its share price in recent times. But, what’s with this recent drop...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.